Skip to main content
Premium Trial:

Request an Annual Quote

NextGen Enters Gene Synthesis Market After Licensing Gene Oracle's GeneIOS Technology

NEW YORK (GenomeWeb News) – NextGen has entered the gene-synthesis market after licensing Gene Oracle's GeneIOS gene-synthesis products and services, NextGen said today.
 
Under the agreement, NextGen will incorporate the GeneIOS technology into a new generation of ContractExpress products. The company will offer the combined technology as part of its fee-for-service offering.
 
NextGen will also offer GeneIOS as a standalone gene-synthesis product in the gene-to-protein development market.
 
NextGen expects to complete the technology transfer in the current quarter. NextGen will pay Gene Oracle technology transfer fees and ongoing royalty payments from commercial activities involving GeneIOS.
 
Additional details were not disclosed.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.